GPR68 and prostate carcinoma: Successively, bone marrow transplantation revealed that GPR68 expression in myeloid-derived blood cells, particularly CD11b+Gr1+ double-positive cells, was required for prostate cancer cell-induced immunosuppression to sustain tumor allografts [161].